Hsing-Wu Chen, Wen-Hung Kuo, Yen-Shen Lu, I-Chun Chen, Fu-Chang Hu, Ming-Yang Wang, Muhammad Zahid, Eleanor G Rogan, Ann-Lii Cheng, Ching-Hung Lin
{"title":"碱基切除修复基因多态性与雌激素-DNA 加合物在东亚妇女乳腺癌风险中的相互作用。","authors":"Hsing-Wu Chen, Wen-Hung Kuo, Yen-Shen Lu, I-Chun Chen, Fu-Chang Hu, Ming-Yang Wang, Muhammad Zahid, Eleanor G Rogan, Ann-Lii Cheng, Ching-Hung Lin","doi":"10.1007/s10549-024-07418-3","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>In East Asia, the incidence of breast cancer has been increasing rapidly, particularly among premenopausal women. An elevated ratio of estrogen-DNA adducts was linked to a higher risk of breast cancer. The present study explored the influence of the interaction between base excision repair (BER) gene polymorphisms and estrogen-DNA adducts on breast cancer risk.</p><p><strong>Methods: </strong>We conducted a case-control study comprising healthy volunteers and individuals with benign breast disease (control arm, n = 176) and patients with invasive carcinoma or carcinoma in situ (case arm, n = 177). Genotyping for BER-related genes, including SMUG1, OGG1, ERCC5, and APEX1, was performed. A logistic regression model, incorporating interactions between gene polymorphisms, estrogen-DNA adduct ratio, and clinical variables, was used to identify the risk factors for breast cancer.</p><p><strong>Results: </strong>Univariate analysis indicated marginal associations between breast cancer risk and APEX1 rs1130409 T > G (P = 0.057) and APEX1 rs1760944 T > G (P = 0.065). Multivariate regression analysis revealed significant associations with increased breast cancer risk for APEX1_rs1130409 (GT/GG versus TT) combined with a natural logarithmic value of the estrogen-DNA adduct ratio (estimated OR 1.164, P = 0.023) and premenopausal status with an estrogen-DNA adduct ratio > 2.93 (estimated OR 2.433, P = 0.001).</p><p><strong>Conclusion: </strong>APEX1_rs1130409 (GT/GG versus TT) polymorphisms, which are related to decreased BER activity, combined with an increased ratio of estrogen-DNA adducts, increase the risk of breast cancer in East Asian women.</p>","PeriodicalId":9133,"journal":{"name":"Breast Cancer Research and Treatment","volume":" ","pages":"283-292"},"PeriodicalIF":3.0000,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Interaction of base excision repair gene polymorphism and estrogen-DNA adducts in breast cancer risk among East Asian women.\",\"authors\":\"Hsing-Wu Chen, Wen-Hung Kuo, Yen-Shen Lu, I-Chun Chen, Fu-Chang Hu, Ming-Yang Wang, Muhammad Zahid, Eleanor G Rogan, Ann-Lii Cheng, Ching-Hung Lin\",\"doi\":\"10.1007/s10549-024-07418-3\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Purpose: </strong>In East Asia, the incidence of breast cancer has been increasing rapidly, particularly among premenopausal women. An elevated ratio of estrogen-DNA adducts was linked to a higher risk of breast cancer. The present study explored the influence of the interaction between base excision repair (BER) gene polymorphisms and estrogen-DNA adducts on breast cancer risk.</p><p><strong>Methods: </strong>We conducted a case-control study comprising healthy volunteers and individuals with benign breast disease (control arm, n = 176) and patients with invasive carcinoma or carcinoma in situ (case arm, n = 177). Genotyping for BER-related genes, including SMUG1, OGG1, ERCC5, and APEX1, was performed. A logistic regression model, incorporating interactions between gene polymorphisms, estrogen-DNA adduct ratio, and clinical variables, was used to identify the risk factors for breast cancer.</p><p><strong>Results: </strong>Univariate analysis indicated marginal associations between breast cancer risk and APEX1 rs1130409 T > G (P = 0.057) and APEX1 rs1760944 T > G (P = 0.065). Multivariate regression analysis revealed significant associations with increased breast cancer risk for APEX1_rs1130409 (GT/GG versus TT) combined with a natural logarithmic value of the estrogen-DNA adduct ratio (estimated OR 1.164, P = 0.023) and premenopausal status with an estrogen-DNA adduct ratio > 2.93 (estimated OR 2.433, P = 0.001).</p><p><strong>Conclusion: </strong>APEX1_rs1130409 (GT/GG versus TT) polymorphisms, which are related to decreased BER activity, combined with an increased ratio of estrogen-DNA adducts, increase the risk of breast cancer in East Asian women.</p>\",\"PeriodicalId\":9133,\"journal\":{\"name\":\"Breast Cancer Research and Treatment\",\"volume\":\" \",\"pages\":\"283-292\"},\"PeriodicalIF\":3.0000,\"publicationDate\":\"2024-11-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Breast Cancer Research and Treatment\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1007/s10549-024-07418-3\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/7/5 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q2\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Breast Cancer Research and Treatment","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s10549-024-07418-3","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/7/5 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0
摘要
目的:在东亚,乳腺癌的发病率迅速上升,尤其是绝经前妇女。雌激素-DNA 加合物比值升高与乳腺癌风险升高有关。本研究探讨了碱基切除修复(BER)基因多态性与雌激素-DNA加合物之间的相互作用对乳腺癌风险的影响:我们进行了一项病例对照研究,研究对象包括健康志愿者和良性乳腺疾病患者(对照组,n = 176)以及浸润癌或原位癌患者(病例组,n = 177)。对 BER 相关基因(包括 SMUG1、OGG1、ERCC5 和 APEX1)进行了基因分型。采用逻辑回归模型,结合基因多态性、雌激素-DNA加合物比值和临床变量之间的相互作用,确定乳腺癌的风险因素:单变量分析表明,乳腺癌风险与APEX1 rs1130409 T > G(P = 0.057)和APEX1 rs1760944 T > G(P = 0.065)之间存在边际关联。多变量回归分析显示,APEX1_rs1130409(GT/GG 与 TT)与雌激素-DNA 加合物比值的自然对数值(估计 OR 1.164,P = 0.023)以及绝经前状态与雌激素-DNA 加合物比值 > 2.93(估计 OR 2.433,P = 0.001)均与乳腺癌风险增加有显著关联:结论:APEX1_rs1130409(GT/GG 与 TT)多态性与 BER 活性降低有关,再加上雌激素-DNA 加合物比率升高,会增加东亚女性罹患乳腺癌的风险。
Interaction of base excision repair gene polymorphism and estrogen-DNA adducts in breast cancer risk among East Asian women.
Purpose: In East Asia, the incidence of breast cancer has been increasing rapidly, particularly among premenopausal women. An elevated ratio of estrogen-DNA adducts was linked to a higher risk of breast cancer. The present study explored the influence of the interaction between base excision repair (BER) gene polymorphisms and estrogen-DNA adducts on breast cancer risk.
Methods: We conducted a case-control study comprising healthy volunteers and individuals with benign breast disease (control arm, n = 176) and patients with invasive carcinoma or carcinoma in situ (case arm, n = 177). Genotyping for BER-related genes, including SMUG1, OGG1, ERCC5, and APEX1, was performed. A logistic regression model, incorporating interactions between gene polymorphisms, estrogen-DNA adduct ratio, and clinical variables, was used to identify the risk factors for breast cancer.
Results: Univariate analysis indicated marginal associations between breast cancer risk and APEX1 rs1130409 T > G (P = 0.057) and APEX1 rs1760944 T > G (P = 0.065). Multivariate regression analysis revealed significant associations with increased breast cancer risk for APEX1_rs1130409 (GT/GG versus TT) combined with a natural logarithmic value of the estrogen-DNA adduct ratio (estimated OR 1.164, P = 0.023) and premenopausal status with an estrogen-DNA adduct ratio > 2.93 (estimated OR 2.433, P = 0.001).
Conclusion: APEX1_rs1130409 (GT/GG versus TT) polymorphisms, which are related to decreased BER activity, combined with an increased ratio of estrogen-DNA adducts, increase the risk of breast cancer in East Asian women.
期刊介绍:
Breast Cancer Research and Treatment provides the surgeon, radiotherapist, medical oncologist, endocrinologist, epidemiologist, immunologist or cell biologist investigating problems in breast cancer a single forum for communication. The journal creates a "market place" for breast cancer topics which cuts across all the usual lines of disciplines, providing a site for presenting pertinent investigations, and for discussing critical questions relevant to the entire field. It seeks to develop a new focus and new perspectives for all those concerned with breast cancer.